Accessibility Menu
TELA Bio logo

TELA Bio

(NASDAQ) TELA

Current Price$0.85
Market Cap$37.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-94%
5 Year-95%
1 Year-59%
1 Month-5%

TELA Bio Financials at a Glance

Market Cap

$37.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$80.81M

Net Income (TTM)

-$39.84M

EPS (TTM)

-$0.80

P/E Ratio

-1.06

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Price

$0.85

Volume

86,969

Open

$0.83

Previous Close

$0.82

Daily Range

$0.81 - $0.91

52-Week Range

$0.50 - $2.19

Estimated Earnings Date

Aug 10, 2026

TELA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TELA Bio

Industry

Healthcare Equipment and Supplies

Employees

218

CEO

Antony Koblish

Headquarters

Malvern, PA 19355, US

TELA Financials

Key Financial Metrics (TTM)

Gross Margin

67.25%

Operating Margin

-41.84%

Net Income Margin

-49.30%

Return on Equity

-1344.47%

Return on Capital

-54.47%

Return on Assets

-57.00%

Earnings Yield

-94.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$37.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

44.77M

Volume

86.97K

Avg. Volume

158.51K

Financials (TTM)

Gross Profit

$54.35M

Operating Income

-$33.81M

EBITDA

-$32.52M

Operating Cash Flow

-$29.66M

Capital Expenditure

-$535.00K

Free Cash Flow

-$30.20M

Cash & ST Invst.

$39.54M

Total Debt

$56.39M

TELA Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$19.06M

+2.9%

Gross Profit

$12.52M

+0.1%

Gross Margin

65.69%

N/A

Market Cap

$37.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$174.73K

N/A

Employees

217

N/A

Net Income

-$12.27M

-9.0%

EBITDA

-$9.90M

-1.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$39.54M

-7.7%

Total Debt

$56.39M

+34.9%

Accounts Receivable

$9.72M

-16.7%

Inventory

$12.21M

-9.8%

Long Term Debt

$55.87M

+35.4%

Short Term Debt

$527.00K

-0.9%

Return on Assets

-57.00%

N/A

Return on Invested Capital

-64.94%

N/A

Free Cash Flow

-$11.29M

-15.7%

Operating Cash Flow

-$11.17M

-14.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
COEPCoeptis Therapeutics Holdings, Inc.
$10.99-8.57%
SRTSSensus Healthcare, Inc.
$3.08+0.98%
CTSOCytosorbents Corporation
$0.38-0.34%
MDAISpectral AI, Inc.
$1.68-2.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$16.31-0.04%
ONDSOndas
$6.96-0.04%
NOKNokia
$11.69-0.06%
INTCIntel
$103.12-0.06%

Questions About TELA

What is the current price of TELA Bio?

TELA Bio is trading at $0.82 per share.

What is the 52-week range for TELA Bio?

Over the past 52 weeks, TELA Bio has traded between $0.50 and $2.19.

How much debt does TELA Bio have?

As of the most recent reporting period, TELA Bio reported total debt of $56.39M.

How much cash does TELA Bio have on hand?

TELA Bio reported $39.54M in cash and cash equivalents in its most recent financial results.

What is TELA Bio’s dividend yield?

TELA Bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.